top of page

January 2019 // Funding

Synendos Therapeutics was successful in winning BaseLaunch competition (Phase II) and was awarded with CHF 250’000. This program enables the company generating critical scientific data and further developing of the business.

Recent Posts

See All

April 2021 // Investment

Synendos Series A Extension Synendos Therapeutics is thrilled to announce an extension to the Series A financing with the addition of Ysios Capital to its syndicate of European investors. Ysios Capita

October 2020 // Funding

Synendos and Prof. Jürg Gertsch received an Innosuisse Innovation Grant (total value of CHF 950’000).


bottom of page